<ѻý>Implant for Ocular Hypertension, Glaucoma Gets FDA Green Lightѻý> A single travoprost implant proved noninferior to timolol eye drops, with good safety Dec 14, 2023
<ѻý>First Pulsed Field Ablation Catheter Approved for Afibѻý> Device is the first of a new class of non-thermal ablation catheters to get FDA's blessing Dec 14, 2023
<ѻý>FDA OKs Maintenance Option for High-Risk Neuroblastomaѻý> Eflornithine approved to reduce relapse risk in both kids and adults Dec 14, 2023
<ѻý>The FDA's Inequitable Conduct Problemѻý> Study finds that about half of all inequitable conduct cases were for FDA-regulated products Dec 12, 2023 video
<ѻý>A Closer Look at the Approval of CRISPR/Cas9 Gene Therapy for Sickle Cell Diseaseѻý> This landmark event brings up broader considerations and implications for other diseases Dec 11, 2023
<ѻý>FDA Inspections of Foreign Drug Manufacturers Haven't Bounced Back After Pandemicѻý> Overseas inspections "well below" pre-pandemic surveillance Dec 08, 2023
<ѻý>Milestone Gene Therapies for Sickle Cell Disease Greenlit by FDAѻý> Casgevy and Lyfgenia approved for one-time treatment of sickle cell disease Dec 08, 2023
<ѻý>FDA Clears First At-Home Kit for Artificial Inseminationѻý> Intravaginal device was deemed "substantially equivalent" to clinically used intrauterine device Dec 07, 2023
<ѻý>FDA Approves Oral Factor B Inhibitor for Paroxysmal Nocturnal Hemoglobinuriaѻý> Iptacopan tops C5 Inhibitors for sustained hemoglobin levels, eliminating need for transfusion Dec 06, 2023
<ѻý>Doc Set Home on Fire? High Blood Pressure in Couples; WHO: Raise Alcohol, Soda Taxesѻý> Health news and commentary from around the Web gathered by ѻý staff Dec 06, 2023
<ѻý>Jamie Foxx's Health Scare; 23andMe Hacked; Decongestant Probe Announcedѻý> Health news and commentary from around the Web gathered by ѻý staff Dec 05, 2023
<ѻý>Don't Neglect Tobacco Use in People Experiencing Homelessnessѻý> Cessation programs can save lives and improve financial stability Dec 04, 2023
<ѻý>Gaming the Patent System Can Keep Biosimilars Off the Market for Decadesѻý> Sean Tu, PhD, JD, explains trade secret laws and patent laws for biologics Dec 04, 2023 video
<ѻý>Non-Covalent BTK Inhibitor Approved for CLLѻý> Response rates with pirtobrutinib reached 72% in heavily pretreated patient population Dec 04, 2023
<ѻý>FDA Clears First Oral Device Treatment for Severe Sleep Apneaѻý> Oral appliances represent an alternative to CPAP and surgical neurostimulation implants Nov 30, 2023
<ѻý>FDA Warns That Philips' CPAP Machines May Overheatѻý> Thermal issues including burns, smoke, fire among reports submitted by DreamStation 2 users Nov 29, 2023
<ѻý>FDA Warns of Rare Life-Threatening Reaction to Anti-Seizure Drugsѻý> Prescribing information changed for levetiracetam, clobazam Nov 28, 2023
<ѻý>FDA Investigating 'Serious Risk' of Malignancy After CAR-T Therapyѻý> Applies to all approved therapies, but benefits still outweigh risks, agency says Nov 28, 2023
<ѻý>FDA Approves First Therapy for Progressive Desmoid Tumorsѻý> Nirogacestat reduced the risk of disease progression or death by 71% in randomized trial Nov 28, 2023
<ѻý>Biden Administration Announces Actions to Strengthen the Drug Supply Chainѻý> Biden will use the Defense Production Act to increase American production of some medications Nov 27, 2023
<ѻý>What to Know About Ongoing Eye Drop Recallsѻý> FDA was spurred into action by a deadly bacterial outbreak earlier this year, advocates say Nov 20, 2023
<ѻý>Drug Candidate for Chronic Cough Rejected by FDA Panelѻý> Gefapixant's benefit not clinically meaningful enough, panelists say Nov 17, 2023
<ѻý>First AKT Inhibitor Approved for Advanced Breast Cancerѻý> Capivasertib plus fulvestrant doubled progression-free survival versus fulvestrant-placebo Nov 17, 2023
<ѻý>Opioid Doc Sentenced; World's First Sickle Cell Gene Tx; FTC Warns Diet Influencersѻý> Health news and commentary from around the Web gathered by ѻý staff Nov 17, 2023
<ѻý>FDA Panel: Tolerating Approval Outliers Would Set 'Dangerous Precedent'ѻý> No easy answers for two drugs for rare lymphoma on long cruise with accelerated approval Nov 16, 2023
<ѻý>First At-Home Test for Chlamydia and Gonorrhea Authorized by FDAѻý> OTC option arrives amid rising cases of the sexually transmitted infections Nov 16, 2023
<ѻý>FDA OKs New Option for Advanced ROS1-Positive Lung Cancerѻý> Drug achieved high response rates in TKI-naive and TKI-pretreated patients Nov 16, 2023
<ѻý>Unclear if Chronic Cough Drug Has Meaningful Benefit, FDA Reviewers Sayѻý> Previously rejected gefapixant will face agency's panel of outside experts on Friday Nov 16, 2023
<ѻý>FDA OKs Product to Thwart Bloodstream Infections During Dialysisѻý> Taurolidine-heparin solution reduced infections by 71% versus heparin alone Nov 15, 2023
<ѻý>Anthrax Guidance Issued; FDA Warns Amazon; AI Deepfakes Challenge Public Healthѻý> Health news and commentary from around the Web gathered by ѻý staff Nov 15, 2023
<ѻý>Lymphoma Drug Copanlisib to Be Pulled From U.S. Marketѻý> Failed confirmatory trial takes down another PI3K inhibitor Nov 14, 2023
<ѻý>Communicating Uncertainty About Drugs Granted Accelerated Approvalѻý> An education gap exists about "the possibility that these drugs might not work," says expert Nov 13, 2023 video
<ѻý>First Treatment Approved for Genetic Clotting Disorderѻý> Adzynma indicated as prophylactic or on-demand enzyme replacement therapy in cTTP Nov 10, 2023
<ѻý>First Chikungunya Vaccine Lands Conditional FDA Approvalѻý> High level of seroprotection, but adverse reactions warrant postmarketing study Nov 10, 2023
<ѻý>Competing Incentives of the FDA's Accelerated Drug Approvalѻý> Experts weigh drug availability against possible suboptimal outcomes Nov 09, 2023 video
<ѻý>New Oral Drug Approved for Metastatic Colorectal Cancerѻý> In phase III trials of pretreated patients, fruquintinib improved survival versus placebo Nov 09, 2023
<ѻý>Tirzepatide Wins FDA Approval for Weight Lossѻý> Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023
<ѻý>FDA Approves First Renal Denervation System for Hypertensionѻý> Catheter-based technology will finally enter the market with ultrasound-based device Nov 08, 2023
<ѻý>FDA Panel Backs High-Risk Designation for Salvaged Blood Irradiatorsѻý> With Class III designation, sponsors would have to prove safety, efficacy with randomized trials Nov 07, 2023
<ѻý>Regulation Gap Persists in OTC Eye Care Productsѻý> Poor oversight, sketchy product information endanger public health, experts say Nov 04, 2023